Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Debt RatioEnterprise ValueInventory AverageInvested Capital

Mesoblast (MESO) EBT Margin (2016 - 2023)

Historic EBT Margin for Mesoblast (MESO) over the last 9 years, with Q2 2023 value amounting to 1026.6%.

  • Mesoblast's EBT Margin fell 595600.0% to 1026.6% in Q2 2023 from the same period last year, while for Jun 2023 it was 1064.17%, marking a year-over-year decrease of 1673300.0%. This contributed to the annual value of 592.0% for FY2025, which is 9015100.0% up from last year.
  • Latest data reveals that Mesoblast reported EBT Margin of 1026.6% as of Q2 2023, which was down 595600.0% from 961.63% recorded in Q1 2023.
  • In the past 5 years, Mesoblast's EBT Margin registered a high of 43.5% during Q3 2019, and its lowest value of 5116.55% during Q2 2020.
  • Its 5-year average for EBT Margin is 1330.61%, with a median of 1124.2% in 2021.
  • Its EBT Margin has fluctuated over the past 5 years, first plummeted by -39013500bps in 2020, then skyrocketed by 39951600bps in 2021.
  • Quarter analysis of 5 years shows Mesoblast's EBT Margin stood at 1217.27% in 2019, then rose by 6bps to 1143.15% in 2020, then increased by 4bps to 1092.11% in 2021, then decreased by -5bps to 1150.75% in 2022, then grew by 11bps to 1026.6% in 2023.
  • Its EBT Margin stands at 1026.6% for Q2 2023, versus 961.63% for Q1 2023 and 1150.75% for Q4 2022.